FM
Insider
Frank McCormick
DirectorFrank McCormick (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $13.2M of BBIO (198,359 sh across 5 lots, as filed), executed Oct 29 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$13.3M
shares × price, as filed
Last traded
Oct 29 2025
Filed Oct 31 2025
Median ADV $293.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $21.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
BBIORecent filings
BBIOSALE
BridgeBio Pharma, Inc.
View filing →
$13.2M198,359 sh across 5 lots
Exec Oct 29 2025
Filed Oct 31 2025 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $107K
1,641 sh × $65.00
Exec Oct 27 2025
Filed Oct 29 2025 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $3.9M
74,000 sh × $53.16
Exec Sep 5 2025
Filed Sep 8 2025 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $4.4M
100,000 sh × $44.23
Exec Jun 24 2025
Filed Jun 26 2025 · 5:30 PM ET